a Systematic Review of the Literature Examining the Effects of Cigarette Smoke and e-Cigarette Vapor on the Virulence of human Pathogenic Bacteria.
Nonclinical
Immunotoxicity
In Vivo
Bagale (2022)
Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens.
Nonclinical
Immunotoxicity
In Vivo
Gilpin (2019)
E-cigarettes: Effects in phagocytosis and cytokines response against Mycobacterium tuberculosis.
Nonclinical
Immunotoxicity
In Vitro
Gómez (2020)
Inflammation and oxidative stress from E-cigarette exposure: implications for COPD and asthma.
Nonclinical
Immunotoxicity
In Vivo
hutchinson (2022)
Comparative assessment of in vitro BBB tight junction integrity following exposure to cigarette smoke and e-cigarette vapor: a quantitative evaluation of the protective effects of metformin using small-molecular-weight paracellular markers.
Nonclinical
Immunotoxicity
In Vitro
Kadry (2021)
Expression of Key Inflammatory Proteins Is Increased in Immune Cells From Tobacco Cigarette Smokers But Not Electronic Cigarette Vapers: Implications for atherosclerosis.
Nonclinical
Immunotoxicity
In Vivo
Kelesidis (2021)
Increased Expression of Proatherogenic Proteins in Immune Cell Subtypes in Tobacco Cigarette Smokers But Not in Electronic Cigarette Vapers.
Nonclinical
Immunotoxicity
In Vivo
Kelesidis (2021)
another Warning Sign: high Nicotine Content in Electronic Cigarettes Disrupts Mucociliary Clearance, the Essential Defense Mechanism of the Lung.
Nonclinical
Immunotoxicity
In Vivo
Kesimer (2019)
Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces aCE2 and Immune Dysregulation.
Nonclinical
Immunotoxicity
In Vitro
Lee (2020)
E-cigarettes Induce Dysregulation of autophagy Leading to Endothelial Dysfunction in Pulmonary arterial hypertension.
Nonclinical
Immunotoxicity
In Vitro
Liu (2023)